Meth and Cocaine Use Disorder in Residential Treatment: The 2-of-11 Rule, No FDA-Approved Medication, and What to Tell Admissions

When a family calls about methamphetamine or cocaine, the first question is almost always some version of “Is there a medication for this, like there is for opioids?” The answer shapes everything else about the admissions process, so it is worth starting there. This guide walks through how stimulant use disorder is diagnosed, what the first week of residential treatment actually looks like, why the treatment plan is built around behavioral care rather than a prescription, and what to have ready when you call admissions.

The Short Answer: Diagnosis Rules and the Medication Gap

Stimulant use disorder, which covers methamphetamine, cocaine and misused prescription stimulants, is diagnosed under the DSM-5 when a person meets at least 2 of 11 criteria within a 12-month period; 2 to 3 criteria is classed as mild, 4 to 5 as moderate and 6 or more as severe. Unlike opioid or alcohol use disorder, there is currently no medication approved by the U.S. Food and Drug Administration specifically to treat stimulant use disorder, so residential treatment for meth or cocaine is built mainly on behavioral therapies such as contingency management and cognitive behavioral therapy, with medical and psychiatric care used to manage sleep, mood and any co-occurring conditions.

The National Institute on Drug Abuse (NIDA) describes behavioral therapies, including contingency management, as the most effective treatments currently available for methamphetamine use disorder, and notes that research into medications is ongoing. That is not a weakness of residential care. It is the reason structure, time and a clinical team matter so much more for stimulants than many families expect.

What the First Week Actually Looks Like

Families often brace for a dramatic physical withdrawal. With stimulants alone, what we usually see instead is a crash. Speaking from years of admissions conversations and placements, the pattern in the first several days is remarkably consistent:

• Days 1 to 3: long stretches of sleep, sometimes 12 hours or more, heavy appetite, irritability and a flat, exhausted mood. Families sometimes worry that their loved one is “doing nothing.” Sleeping is the work at this stage.
• Days 4 to 7: energy starts to return unevenly. Low mood, anxiety and intense cravings often come in waves, frequently triggered by boredom, a phone call or a memory.
• Weeks 2 to 4: sleep begins to normalize for many people, but anhedonia, the sense that nothing feels rewarding, can linger. This is the stretch where people most often want to leave, saying “I feel fine now.”

Timelines vary from person to person, and these are clinical observations rather than fixed rules. The key point is that the most dangerous period for leaving early is usually not day one, but the second and third week, when the crash has lifted and the brain’s reward system has not yet recovered.

Why Stimulant Withdrawal Still Needs Clinical Oversight

Withdrawal from stimulants alone is generally not considered physically life-threatening in the way alcohol withdrawal can be. That does not mean it is safe to go it alone. Three mechanisms drive the clinical risk:

Post-crash depression: mood can drop sharply in the days after heavy use stops, and some people experience suicidal thoughts that need same-day psychiatric assessment.

Stimulant-induced psychosis: paranoia, hallucinations or agitation can persist after use stops, particularly after prolonged methamphetamine use, and require medical evaluation rather than waiting it out.

Hidden co-use: many people who use stimulants also use alcohol, benzodiazepines or opioids to come down or sleep, and withdrawal from alcohol and benzodiazepines carries a real risk of seizures that requires medical supervision.

That third point is the inconvenient truth of stimulant admissions. In our experience, the substance a family calls about is often not the one that determines the level of care. A person described as “only using meth” who also drinks every night to sleep may need medically supervised detox before or at the start of residential treatment. Never stop alcohol or benzodiazepines abruptly without a medical team involved.

If you or a loved one is having thoughts of suicide, call or text 988, the Suicide and Crisis Lifeline, or call 911 in an emergency.

How Treatment Is Structured Without a Medication

Because there is no FDA-approved medication, a strong residential program for stimulant use disorder is defined by what it does with the day. When you compare programs, these are the components to look for:

• Contingency management: a structured system that provides tangible rewards for verified outcomes such as negative drug tests. SAMHSA has supported wider use of contingency management for stimulant use disorders, and it is one of the best-studied approaches available.
• Cognitive behavioral therapy: practical work on identifying triggers, planning for high-risk situations and handling cravings without acting on them.
• Psychiatric evaluation: screening for depression, anxiety, ADHD, bipolar disorder and psychosis, since co-occurring conditions are common and can be mistaken for, or masked by, stimulant effects.
• Sleep and nutrition support: weight loss, dental problems and badly disrupted sleep are common after long stimulant runs, and recovery goes better when the body is rebuilt alongside the mind.
• Family involvement: education for relatives about the crash, the “I feel fine” phase and what a realistic aftercare plan looks like.

Medications may still be part of a person’s care, for example to treat co-occurring depression or to support sleep, but those decisions belong to the prescribing clinician and are made case by case. You can learn more about how this level of care works on our residential treatment page.

The Fentanyl Factor

The Centers for Disease Control and Prevention (CDC) has reported that a growing share of overdose deaths involving stimulants also involve opioids, particularly illegally made fentanyl. Some of that is intentional co-use, and some is contamination the person never knew about. For admissions, this means two things: the clinical team will want to know about any possible opioid exposure, and the discharge plan should include naloxone and overdose education, because tolerance drops during treatment.

What to Do Before You Call Admissions

The most useful thing you can do today is write down the following before the call, even if the answers are rough estimates. Admissions teams use this to decide whether a person needs detox first, residential care directly, or a different level of care entirely.

1. Last use: the date and approximate time stimulants were last used.
2. Pattern: how often, how much and by what route (smoked, snorted, injected), and how long the current run has lasted.
3. Everything else: every other substance in the past 30 days, especially alcohol, sleeping pills, benzodiazepines such as Xanax or Klonopin, and any opioids.
4. Sleep: roughly how many hours the person has slept in the last 72 hours.
5. Mental health: any paranoia, hallucinations, or talk of self-harm or suicide, past or present.
6. Prescriptions and insurance: a current medication list and an insurance card. You can start the benefits check now through our insurance verification page.

Then ask the program three direct questions: “Do you use contingency management, and how?”, “How do you handle the second and third week, when people want to leave?” and “What does your aftercare plan include for stimulant use?” A program that answers these clearly has thought about stimulant recovery specifically, not just addiction in general.

To talk through a specific situation, call (877) 328-1968.

After Residential: Planning the Step-Down

Cravings for stimulants can resurface weeks or months after the crash has passed, often in response to people, places or even payday. That is why the step-down plan matters as much as the residential stay. Most people benefit from moving into a structured outpatient program rather than going straight home without support, with continued therapy, peer support and, where available, ongoing contingency management.

Recovery from stimulant use disorder is possible, and many people do recover with time and the right structure. If you are trying to figure out the right level of care for yourself or someone you love, our team can walk through the options and the insurance questions with you. Call (877) 328-1968 to speak with someone today.

This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Withdrawal from alcohol or benzodiazepines can cause seizures and must be medically supervised. If you are experiencing a medical emergency, call 911. If you are in crisis or having thoughts of suicide, call or text 988.